157 related articles for article (PubMed ID: 15695332)
1. Suppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signaling.
Nicholson SE; Metcalf D; Sprigg NS; Columbus R; Walker F; Silva A; Cary D; Willson TA; Zhang JG; Hilton DJ; Alexander WS; Nicola NA
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2328-33. PubMed ID: 15695332
[TBL] [Abstract][Full Text] [Related]
2. The suppressors of cytokine signalling (SOCS).
Kile BT; Alexander WS
Cell Mol Life Sci; 2001 Oct; 58(11):1627-35. PubMed ID: 11706989
[TBL] [Abstract][Full Text] [Related]
3. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.
Nicholson SE; Willson TA; Farley A; Starr R; Zhang JG; Baca M; Alexander WS; Metcalf D; Hilton DJ; Nicola NA
EMBO J; 1999 Jan; 18(2):375-85. PubMed ID: 9889194
[TBL] [Abstract][Full Text] [Related]
4. Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling.
Kario E; Marmor MD; Adamsky K; Citri A; Amit I; Amariglio N; Rechavi G; Yarden Y
J Biol Chem; 2005 Feb; 280(8):7038-48. PubMed ID: 15590694
[TBL] [Abstract][Full Text] [Related]
5. The many faces of the SOCS box.
Piessevaux J; Lavens D; Peelman F; Tavernier J
Cytokine Growth Factor Rev; 2008; 19(5-6):371-81. PubMed ID: 18948053
[TBL] [Abstract][Full Text] [Related]
6. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
Vacca F; Bagnato A; Catt KJ; Tecce R
Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras.
Cacalano NA; Sanden D; Johnston JA
Nat Cell Biol; 2001 May; 3(5):460-5. PubMed ID: 11331873
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
9. SOCS proteins in regulation of receptor tyrosine kinase signaling.
Kazi JU; Kabir NN; Flores-Morales A; Rönnstrand L
Cell Mol Life Sci; 2014 Sep; 71(17):3297-310. PubMed ID: 24705897
[TBL] [Abstract][Full Text] [Related]
10. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
van de Geijn GJ; Gits J; Touw IP
J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
[TBL] [Abstract][Full Text] [Related]
11. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130.
Nicholson SE; De Souza D; Fabri LJ; Corbin J; Willson TA; Zhang JG; Silva A; Asimakis M; Farley A; Nash AD; Metcalf D; Hilton DJ; Nicola NA; Baca M
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6493-8. PubMed ID: 10829066
[TBL] [Abstract][Full Text] [Related]
12. The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression.
Babon JJ; Sabo JK; Zhang JG; Nicola NA; Norton RS
J Mol Biol; 2009 Mar; 387(1):162-74. PubMed ID: 19385048
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
14. The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing.
Waterman H; Alroy I; Strano S; Seger R; Yarden Y
EMBO J; 1999 Jun; 18(12):3348-58. PubMed ID: 10369675
[TBL] [Abstract][Full Text] [Related]
15. The suppressors of cytokine signalling E3 ligases behave as tumour suppressors.
Elliott J; Hookham MB; Johnston JA
Biochem Soc Trans; 2008 Jun; 36(Pt 3):464-8. PubMed ID: 18481982
[TBL] [Abstract][Full Text] [Related]
16. The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.
Visser GD; Lill NL
Exp Cell Res; 2005 Dec; 311(2):281-93. PubMed ID: 16246327
[TBL] [Abstract][Full Text] [Related]
17. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
18. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor.
Dey BR; Furlanetto RW; Nissley P
Biochem Biophys Res Commun; 2000 Nov; 278(1):38-43. PubMed ID: 11071852
[TBL] [Abstract][Full Text] [Related]
19. Ankyrin repeat and suppressors of cytokine signaling box protein asb-9 targets creatine kinase B for degradation.
Debrincat MA; Zhang JG; Willson TA; Silke J; Connolly LM; Simpson RJ; Alexander WS; Nicola NA; Kile BT; Hilton DJ
J Biol Chem; 2007 Feb; 282(7):4728-4737. PubMed ID: 17148442
[TBL] [Abstract][Full Text] [Related]
20. A new role for SOCS in insulin action. Suppressor of cytokine signaling.
Krebs DL; Hilton DJ
Sci STKE; 2003 Feb; 2003(169):PE6. PubMed ID: 12582200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]